retatrutide phase 2 weight loss Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized 2a trial Retatrutide vs Tirzepatide: Which Peptide

The GLP-1 receptor agonist exenatide improves recovery from spinal cord injury by inducing macrophage polarization toward the M2 phenotype

GLP-1 aids in regulating insulin, enhances satiety, and supports blood sugar control

What happens if you stop tirzepatide If you discontinue tirzepatide for any reason, your levothyroxine requirements may shift back toward your original dose

The FDA-approved labels for these medications clearly list gastrointestinal adverse reactions as among the most frequently reported, with nausea being the most common, followed by vomiting, diarrhea, constipation, and abdominal pain

In September 2025, the FDA sent thousands of warning letters and issued approximately 100 cease-and-desist letters to companies regarding their use of misleading direct-to-consumer pharmaceutical advertisements. The agency also published a green list of acceptable GLP-1 compounding ingredients intended to regulate ingredient sourcing and reduce the risk of unsafe compounded products

Seven trials are running, with results expected throughout the remainder of this year